Autofluorescence Imaging Resolves Early Cancer Treatment Response In Vivo

Optical Molecular Probes, Imaging and Drug Delivery, OMP 2013(2013)

引用 1|浏览4
暂无评分
摘要
NADH and FAD auto-fluorescence intensity and lifetime imaging are used to monitor breast cancer metabolism. In vivo imaging of xenograft tumors revealed metabolic differences in responsive but not resistant tumors treated with trastuzumab at earlier time points than FDG-PET.
更多
查看译文
关键词
autofluorescence imaging resolves,early cancer treatment response
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要